These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 26884383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin 1β regulation of FoxO1 protein content and localization: evidence for a novel ceramide-dependent mechanism.
    Dobierzewska A, Shi L, Karakashian AA, Nikolova-Karakashian MN.
    J Biol Chem; 2012 Dec 28; 287(53):44749-60. PubMed ID: 23105097
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TXNDC5 contributes to rheumatoid arthritis by down-regulating IGFBP1 expression.
    Li J, Xu B, Wu C, Yan X, Zhang L, Chang X.
    Clin Exp Immunol; 2018 Apr 28; 192(1):82-94. PubMed ID: 29131315
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
    Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF.
    Endocrinology; 2007 Jan 28; 148(1):241-51. PubMed ID: 17038556
    [Abstract] [Full Text] [Related]

  • 10. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ, Tang Q, Wu J, Chen Y, Zheng F, Dai Z, Hann SS.
    J Exp Clin Cancer Res; 2016 Mar 31; 35():59. PubMed ID: 27036874
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. O-GlcNAcylation of FoxO1 in pancreatic β cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism.
    Fardini Y, Masson E, Boudah O, Ben Jouira R, Cosson C, Pierre-Eugene C, Kuo MS, Issad T.
    FASEB J; 2014 Feb 31; 28(2):1010-21. PubMed ID: 24174424
    [Abstract] [Full Text] [Related]

  • 19. Identification of a region in the human IRS2 promoter essential for stress induced transcription depending on SP1, NFI binding and ERK activation in HepG2 cells.
    Udelhoven M, Leeser U, Freude S, Hettich MM, Laudes M, Schnitker J, Krone W, Schubert M.
    J Mol Endocrinol; 2010 Feb 31; 44(2):99-113. PubMed ID: 19755487
    [Abstract] [Full Text] [Related]

  • 20. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ.
    Clin Sci (Lond); 2015 Nov 31; 129(10):839-50. PubMed ID: 26201094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.